P. Gable

发表

A multicenter, phase III randomized trial for stage IIIB/IV NSCLC of weekly paclitaxel and carboplatin vs. standard paclitaxel and carboplatin given every three weeks, followed by weekly paclitaxel.

C. Belani, W. Tester, D. Rinaldi, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Protac, a commercially available protein C activator from the venom of Agkistrodon contortrix contortrix, can activate factor V and factor VIII.

S. Rapaport, D. Le, P. Gable, 1997, Thrombosis research.

Superior Mesenteric Vein Thrombosis Mimicking Acute Appendicitis

M. Gaspary, J. Auten, P. Gable, 2011, The western journal of emergency medicine.

Mucormycosis as the Elusive Cause of an Aortic Thrombus and Tissue-Obliterating Abscess

P. Gable, S. R. Paul, 2019, Case reports in hematology.

Antiandrogen withdrawal alone or in combination with ketoconazole in androgen-independent prostate cancer patients: a phase III trial (CALGB 9583).

E. Small, B. Rini, J. Picus, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy and tolerability of intravenous ferric gluconate in the treatment of iron deficiency anemia in patients without kidney disease.

P. Gable, James Hu, H. Miller, 2007, Archives of internal medicine.

Primitive neuroectodermal tumor of the uterus.

M. McHale, P. Gable, M. M. Quigley, 2007, Gynecologic oncology.

Comparison of outcomes for elderly patients treated with weekly paclitaxel in combination with carboplatin versus the standard 3‐weekly paclitaxel and carboplatin for advanced nonsmall cell lung cancer

S. Ramalingam, M. Perry, C. Belani, 2008, Cancer.

Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancer.

S. Ramalingam, M. Perry, C. Belani, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

O-093 Meta-analysis of weekly paclitaxel as maintenance therapy foradvanced non-small cell lung cancer (NSCLC) patients following intitial chemotherapy

S. Ramalingam, M. Perry, C. Belani, 2005 .

Extramedullary hematopoiesis presenting as an intraatrial mass in a patient with chronic myelogenous leukemia.

K. Bethel, R. Freeman, P. Gable, 1995, The Journal of thoracic and cardiovascular surgery.

A Protac®-based screening test for activated protein C-resistant factor Va and other defects of the protein C anticoagulant pathway

S. Rapaport, P. Gable, D. T. Le, 1997, Blood Coagulation and Fibrinolysis.